Navigation path

Community Register of medicinal products

Community register of orphan medicinal products


GRANTED  

Product information

Tretazicar

EU orphan designation number: EU/3/08/529   
Active ingredient: Tretazicar
Indication: Treatment of visceral leishmaniasis
Sponsor: Morvus Technology Limited
The Science Centre, National Botanic Gardens of Wales, Llanarthney, Carmarthenshire SA32 8HZ, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
07/02/2008 Centralised Orphan - Designation EMEA/OD/095/07 (2008)498 of 04/02/2008
15/08/2011 Corrigendum - (2011)5933 of 10/08/2011